INS and Hypoglycemia: In clinical practice, during thetitration phase when these insulins are initiated, at a minimum, more frequent monitoringwill be needed not only to gauge glycemic response but also for hypoglycemia detection.One can argue that CGM would be useful in this regard since it will provide data over notonly the course of 1 day but the whole week, allowing for monitoring for recovery as wellas recurrence of hypoglycemia (163).